July 28, 2011

OriGene Technologies Reaches 3000 TrueMAB(TM) Monoclonal Antibodies

3000 Highly Validated Monoclonal Antibodies Made Against Native Protein Epitopes Expands OriGene's Antibody Portfolio to Over 7500

ROCKVILLE, Md., July 28, 2011 /PRNewswire-USNewswire/ -- OriGene Technologies, Inc. a gene-centric life sciences company, today announced that through its July release, the TrueMAB(TM) monoclonal antibodies have reached the 3000 product milestone. Each TrueMAB, made against antigens produced mostly in HEK293T cells, has proven superior in performance for immunoassays that are sensitive to proteins' native conformations. The development further expands the company's overall monoclonal and polyclonal antibody offering to over 7500 in total.

Available immediately at http://www.origene.com/Antibody/TrueMAB/, this new addition of TrueMAB brand antibodies supports OriGene's commitment to building the largest and most specific monoclonal antibody portfolio in the world. Each antibody has been comprehensively tested in multiple applications including IHC, IF, IP, Flow and WB. "The extensive validation and exceptional performance of our TrueMAB monoclonal antibodies allows us to provide quality products to meet the critical research and diagnostic needs of our customers," commented Wei-Wu He, Ph.D., CEO & Chairman, OriGene Technologies. "We are proud of achieving this milestone in just two years."

Further TrueMAB(TM) Monoclonal Antibody product and ordering information can be found online at http://www.origene.com/Antibody/TrueMAB/.

About OriGene Technologies

OriGene Technologies, Inc., is a gene-centric life sciences company dedicated to support academic, pharmaceutical and biotech companies in their research of gene functions and drug discovery. OriGene develops proteins, antibodies, and other molecular tools to allow researchers to analyze their data on a multiplex level. OriGene's novel product line includes the world's largest cDNA and shRNA clone collections, over 5,000 purified human proteins, high quality monoclonal antibodies (TrueMAB(TM)),100,000 highly validated human tissues, and protein microarray products and services. OriGene also provides a broad range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from our tissue collection. For more information, visit www.origene.com.

TrueMAB is a trademark of OriGene Technologies, Inc.

SOURCE OriGene Technologies, Inc.